Global Carbapenem Antibiotics Competitive Landscape Professional Research Report 2025
Description
Global Carbapenem Antibiotics Competitive Landscape Professional Research Report 2025
Research Summary
Carbapenem antibiotics are a class of broad-spectrum antibiotics known for their potent activity against a wide range of bacterial infections. They belong to the beta-lactam family of antibiotics and are often considered as the ＂last-resort＂ treatment option for severe bacterial infections that are resistant to other antibiotics. Carbapenems work by inhibiting the synthesis of bacterial cell walls, leading to the disruption of bacterial growth and ultimately causing their death. They are effective against both Gram-positive and Gram-negative bacteria, including multi-drug resistant strains. Due to their broad-spectrum activity and efficacy, carbapenems are commonly used in hospital settings for treating serious infections such as pneumonia, urinary tract infections, intra-abdominal infections, and bloodstream infections caused by various bacteria. However, due to the emergence of carbapenem-resistant organisms, the appropriate use and careful monitoring of carbapenem antibiotics are crucial to preserve their effectiveness.
According to DIResearch's in-depth investigation and research, the global Carbapenem Antibiotics market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Carbapenem Antibiotics include ACS Dobfar, Iterum Therapeutics plc, DAEWOONG PHARMACEUTICAL, Aurobindo Pharma, Merck, Gland Pharma Limited, Sumitomo Dainippon Pharma, Savior Lifetec, Pfizer Inc., Spero Therapeutics etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Carbapenem Antibiotics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Carbapenem Antibiotics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Carbapenem Antibiotics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Carbapenem Antibiotics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Carbapenem Antibiotics Include:
ACS Dobfar
Iterum Therapeutics plc
DAEWOONG PHARMACEUTICAL
Aurobindo Pharma
Merck
Gland Pharma Limited
Sumitomo Dainippon Pharma
Savior Lifetec
Pfizer Inc.
Spero Therapeutics
Carbapenem Antibiotics Product Segment Include:
Meropenem
Donipenem
Imipenem
Tipipenem
Others
Carbapenem Antibiotics Product Application Include:
Retail Pharmacy
Online Pharmacy
Hospital Pharmacy
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Carbapenem Antibiotics Industry PESTEL Analysis
Chapter 3: Global Carbapenem Antibiotics Industry Porter’s Five Forces Analysis
Chapter 4: Global Carbapenem Antibiotics Major Regional Market Size and Forecast Analysis
Chapter 5: Global Carbapenem Antibiotics Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Carbapenem Antibiotics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Carbapenem Antibiotics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Carbapenem Antibiotics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Carbapenem Antibiotics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Carbapenem Antibiotics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Carbapenem Antibiotics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Carbapenem Antibiotics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Carbapenem Antibiotics Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Carbapenem Antibiotics Product by Type
- 1.2.1 Meropenem
- 1.2.2 Donipenem
- 1.2.3 Imipenem
- 1.2.4 Tipipenem
- 1.2.5 Others
- 1.3 Carbapenem Antibiotics Product by Application
- 1.3.1 Retail Pharmacy
- 1.3.2 Online Pharmacy
- 1.3.3 Hospital Pharmacy
- 1.4 Global Carbapenem Antibiotics Market Size Analysis (2020-2032)
- 1.5 Carbapenem Antibiotics Market Development Status and Trends
- 1.5.1 Carbapenem Antibiotics Industry Development Status Analysis
- 1.5.2 Carbapenem Antibiotics Industry Development Trends Analysis
- 2 Carbapenem Antibiotics Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Carbapenem Antibiotics Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Carbapenem Antibiotics Market Analysis by Regions
- 4.1 Carbapenem Antibiotics Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Carbapenem Antibiotics Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Carbapenem Antibiotics Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Carbapenem Antibiotics Revenue Forecast by Region (2026-2032)
- 5 Global Carbapenem Antibiotics Market Size by Type and Application
- 5.1 Global Carbapenem Antibiotics Market Size by Type (2020-2032)
- 5.2 Global Carbapenem Antibiotics Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Carbapenem Antibiotics Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Carbapenem Antibiotics Market Size by Type
- 6.4 North America Carbapenem Antibiotics Market Size by Application
- 6.5 North America Carbapenem Antibiotics Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Carbapenem Antibiotics Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Carbapenem Antibiotics Market Size by Type
- 7.4 Europe Carbapenem Antibiotics Market Size by Application
- 7.5 Europe Carbapenem Antibiotics Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Carbapenem Antibiotics Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Carbapenem Antibiotics Market Size by Type
- 8.4 China Carbapenem Antibiotics Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Carbapenem Antibiotics Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Carbapenem Antibiotics Market Size by Type
- 9.4 APAC (excl. China) Carbapenem Antibiotics Market Size by Application
- 9.5 APAC (excl. China) Carbapenem Antibiotics Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Carbapenem Antibiotics Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Carbapenem Antibiotics Market Size by Type
- 10.4 Latin America Carbapenem Antibiotics Market Size by Application
- 10.5 Latin America Carbapenem Antibiotics Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Carbapenem Antibiotics Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Carbapenem Antibiotics Market Size by Type
- 11.4 Middle East & Africa Carbapenem Antibiotics Market Size by Application
- 11.5 Middle East & Africa Carbapenem Antibiotics Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Carbapenem Antibiotics Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Carbapenem Antibiotics Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Carbapenem Antibiotics Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 ACS Dobfar
- 13.1.1 ACS Dobfar Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 ACS Dobfar Carbapenem Antibiotics Product Portfolio
- 13.1.3 ACS Dobfar Carbapenem Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Iterum Therapeutics plc
- 13.2.1 Iterum Therapeutics plc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Iterum Therapeutics plc Carbapenem Antibiotics Product Portfolio
- 13.2.3 Iterum Therapeutics plc Carbapenem Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 DAEWOONG PHARMACEUTICAL
- 13.3.1 DAEWOONG PHARMACEUTICAL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 DAEWOONG PHARMACEUTICAL Carbapenem Antibiotics Product Portfolio
- 13.3.3 DAEWOONG PHARMACEUTICAL Carbapenem Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Aurobindo Pharma
- 13.4.1 Aurobindo Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Aurobindo Pharma Carbapenem Antibiotics Product Portfolio
- 13.4.3 Aurobindo Pharma Carbapenem Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Merck
- 13.5.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Merck Carbapenem Antibiotics Product Portfolio
- 13.5.3 Merck Carbapenem Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Gland Pharma Limited
- 13.6.1 Gland Pharma Limited Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Gland Pharma Limited Carbapenem Antibiotics Product Portfolio
- 13.6.3 Gland Pharma Limited Carbapenem Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Sumitomo Dainippon Pharma
- 13.7.1 Sumitomo Dainippon Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Sumitomo Dainippon Pharma Carbapenem Antibiotics Product Portfolio
- 13.7.3 Sumitomo Dainippon Pharma Carbapenem Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Savior Lifetec
- 13.8.1 Savior Lifetec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Savior Lifetec Carbapenem Antibiotics Product Portfolio
- 13.8.3 Savior Lifetec Carbapenem Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Pfizer Inc.
- 13.9.1 Pfizer Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Pfizer Inc. Carbapenem Antibiotics Product Portfolio
- 13.9.3 Pfizer Inc. Carbapenem Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Spero Therapeutics
- 13.10.1 Spero Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Spero Therapeutics Carbapenem Antibiotics Product Portfolio
- 13.10.3 Spero Therapeutics Carbapenem Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Carbapenem Antibiotics Industry Chain Analysis
- 14.2 Carbapenem Antibiotics Industry Raw Material and Suppliers Analysis
- 14.2.1 Carbapenem Antibiotics Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Carbapenem Antibiotics Typical Downstream Customers
- 14.4 Carbapenem Antibiotics Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
